Abstract
Many biologic agents are available to treat psoriasis, however only a few reports investigate the efficacy and safety of these agents in patients with psoriasis complicated by kidney failure. In this report we detail a case of severe plaque psoriasis complicated with end-stage renal disease (ESRD), successfully treated with ustekinumab without need for dose adjustment.
Original language | English |
---|---|
Pages (from-to) | 342-344 |
Number of pages | 3 |
Journal | SKIN: Journal of Cutaneous Medicine |
Volume | 4 |
Issue number | 4 |
DOIs | |
State | Published - 12 Jul 2020 |
Keywords
- end stage renal disease
- psoriasis
- ustekinumab